arrow
C

Carlo Fumagalli

university of campania luigi vanvitelli
H指数:28
被引数:2,830

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact

家族性遗传性甲状腺素转运蛋白淀粉样变性中的级联遗传筛查:诊断与预后影响

2026-04-070
OA
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study

GLP-1受体激动剂与2型糖尿病患者升主动脉扩张的减少相关:一项前瞻性研究

2025-10-140
OAAI
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug

慢性冠状动脉综合征患者中的雷诺嗪:真实世界数据为该药物的抗心律失常特性提供了新的证据

2025-10-010
OA
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study

联合SGLT2抑制剂和GLP-1受体激动剂治疗对接受慢性抗糖尿病药物治疗的患者中CRT反应和临床结局的影响:一项多中心观察性研究

2025-09-030
OAAI
Correction: Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis

更正:虚弱及照护者关系质量在诊断为甲状腺素转运蛋白心脏淀粉样变性老年患者中的研究

2025-07-030
OAAI
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis

美国心脏病学会/美国心脏协会心力衰竭分期系统突出了诊断延迟,并预测了甲状腺素转运蛋白心脏淀粉样变性的预后

2025-05-240
PRE
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients?

Ghrelin表达能否调节2型糖尿病肥胖患者的舒张性心功能?

2025-05-050
OA
Change in prevalence of ATTR variants in Italy: results from a national survey

Fumagalli, C.; Longhi, S.; Aimo, A.; Argirò, A.; Barilaro, A.; Biagini, E.; Biagioni, G.; Ceccanti, M.; Cipriani, A.; Chimenti, C.; 等. 意大利ATTR变异患病率的变化——全国调查结果. Eur. Heart J. Qual. Care Clin. Outcomes. 2025, qcaf024. [Google Scholar] [CrossRef]

2025-05-017
PRE
PCSK9 Inhibitors Fast Track Use Versus Stepwise Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a Real-World Population

PCSK9抑制剂快速通道使用与逐步降脂疗法在急性冠状动脉综合征患者中的比较:一项真实世界人群的单中心回顾性研究

2025-04-260
OA
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis

转甲状腺素蛋白心脏淀粉样变性中虚弱症的临床表型与预后意义

2025-04-011
OAAI
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis
2024-12-120
OA
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry
2024-10-220
PRE
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy
2024-08-011
PRE